(Q30657347)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Clinical pharmacokinetics of docetaxel (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

S J Clarke

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

99-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092957%20AND%20SRC:MED&resulttype=core&format=json

Plasma concentrations of polysorbate 80 measured in patients following administration of docetaxel or etoposide

12 November 2019

cites work

1 reference

12 December 2020

Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method

1 reference

12 December 2020

Preclinical evaluation of docetaxel (Taxotere).

1 reference

12 December 2020

Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience.

1 reference

12 December 2020

Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs

1 reference

12 December 2020

Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours

1 reference

12 December 2020

Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers

1 reference

12 December 2020

Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation

1 reference

12 December 2020

Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80.

1 reference

12 December 2020

Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL.

1 reference

12 December 2020

Isolation, purification and biological activity of major docetaxel metabolites from human feces.

1 reference

12 December 2020

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer

1 reference

12 December 2020

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer

1 reference

12 December 2020

Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans

1 reference

12 December 2020

Biotransformation of taxoids by human cytochromes P450: structure-activity relationship

1 reference

12 December 2020

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1 reference

12 December 2020

Docetaxel and paclitaxel inhibit DNA-adduct formation and intracellular accumulation of cisplatin in human leukocytes

1 reference

12 December 2020

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of docetaxel: results of phase I and phase II trials

1 reference

12 December 2020

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

1 reference

12 December 2020

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

1 reference

12 December 2020

Docetaxel and cyclophosphamide in patients with advanced solid tumors

1 reference

12 December 2020

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

1 reference

12 December 2020

Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats

1 reference

12 December 2020

Evaluation of the linearity of docetaxel pharmacokinetics.

1 reference

12 December 2020

Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction

1 reference

12 December 2020

Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein

1 reference

12 December 2020

Early clinical studies with docetaxel. Docetaxel Investigators Group

1 reference

12 December 2020

A population pharmacokinetic model for docetaxel (Taxotere): model building and validation

1 reference

12 December 2020

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors

1 reference

12 December 2020

1 reference

12 December 2020

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer

1 reference

12 December 2020

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice

1 reference

12 December 2020

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

1 reference

12 December 2020

Docetaxel (Taxotere) and vinorelbine in the treatment of advanced non-small cell lung cancer: preliminary results of a phase I/II trial

1 reference

12 December 2020

Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial

1 reference

12 December 2020

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

1 reference

12 December 2020

Hepatic metabolism and biliary excretion of Taxol in rats and humans

1 reference

12 December 2020

Preclinical pharmacokinetics of paclitaxel and docetaxel

1 reference

12 December 2020

Promotion of microtubule assembly in vitro by taxol

1 reference

12 December 2020

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

1 reference

12 December 2020

Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer

1 reference

12 December 2020

Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL

1 reference

12 December 2020

Docetaxel combined with vinorelbine: phase I results and new study designs

1 reference

12 December 2020

Preclinical pharmacology of docetaxel

1 reference

12 December 2020

Feminization of rat hepatic P-450 expression by cisplatin. Evidence for perturbations in the hormonal regulation of steroid-metabolizing enzymes

1 reference

12 December 2020

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

1 reference

12 December 2020

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

1 reference

12 December 2020

Phase I trial of Taxotere: five-day schedule

1 reference

12 December 2020

Taxol and taxotere in bladder cancer: in vitro activity and urine stability

1 reference

12 December 2020